Skip to main content
. 2020 Apr 21;11:458. doi: 10.3389/fphar.2020.00458

Figure 6.

Figure 6

Danqi Pill (DQP) targeted on HIF-1α/PGC-1α signaling pathway and finally elevated cardiac energy metabolism in the failing heart.